▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3604 by analyst upside · 2026-11-12
SYK
Stryker Corporation
Healthcare · Market Cap $121B · P/E 33.9x
ANALYST PRICE TARGET
+6.2%
implied upside to consensus target
Current Price $318.79
Consensus Target $338.45
Bull Target $410.0
Bear Target $275.0
Analysts Covering 27
ANALYST CONSENSUS - BUY
Strong Buy
7
Buy
13
Hold
7
Sell
0
52-Week Low $267.0
52-Week High $389.33
YTD Return -7.7%
FUNDAMENTALS
Market Cap $121B
P/E Ratio (TTM) 33.9x
Forward P/E 19.6x
EPS (TTM) $9.39
PEG Ratio 1.56
Dividend Yield 1.09%
Revenue (TTM) $26.3B
Profit Margin 13.8%
52-WEEK RANGE
52-Week Low $267.0
52-Week High $389.33
Current Price $318.79
Bear Target $275.0
Bull Target $410.0
● Now $318.79 ● Target $338.45
TRADING DATA
Avg Volume 2.9M
YTD Return -7.7%
Analyst Count 27
Consensus Buy
Upside to Target +6.2%
Last Updated 2026-11-12

ANALYST SUMMARY

Stryker Corporation (SYK) is currently trading at $318.79 with a Wall Street consensus price target of $338.45, implying potential upside of 6.2% over the next 12 months. 27 analysts currently cover SYK, with a consensus rating of Buy - 74% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $410.0, while the most cautious has a target of $275.0.

SYK operates in the Healthcare sector with a market capitalisation of $121B. The stock is down 7.7% year-to-date and is currently trading near the lower end of its 52-week range of $267.0 – $389.33.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SYK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Truist Securities reit
Hold → Hold 2026-11-02 Building track record
Stifel - Reiterated
Buy → Buy 2026-11-02 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-10-31 43% win rate (7 calls)
Citigroup - Reiterated
Buy → Buy 2026-10-30 Building track record
TD Cowen - Reiterated
Hold → Hold 2026-10-30 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-10-30 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-10-30 Building track record
Canaccord Genuity ↓ Downgrade
Buy → Hold 2026-10-30 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
61
out of 100
Coverage depth
25/30
Consensus clarity
22/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →